Bispecific Antibody Therapy for Treating Relapsed and Refractory Multiple Myeloma
Dana-Farber Cancer Institute via YouTube
AI, Data Science & Cloud Certificates from Google, IBM & Meta
Master Windows Internals - Kernel Programming, Debugging & Architecture
Overview
AI, Data Science & Cloud Certificates from Google, IBM & Meta — 40% Off
One plan covers every Professional Certificate on Coursera. 40% off Coursera Plus Annual.
Unlock All Certificates
Explore a comprehensive medical lecture where Dr. Shonali Midha from Dana-Farber Cancer Institute examines the emerging role and therapeutic potential of bispecific antibodies in treating relapsed/refractory multiple myeloma, providing valuable insights into this innovative treatment approach for healthcare professionals and researchers in the field of hematologic oncology.
Syllabus
Bispecific Antibody Therapy in Multiple Myeloma
Taught by
Dana-Farber Cancer Institute